IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
Abstract Background Treatment for neonatal alloimmune thrombocytopenia (NAIT) primarily involves maternal administration of intravenous immunoglobulin (IVIG) therapy and prednisone according to protocols based on risk stratification. While IVIG is generally well tolerated, hematologic s...
Main Authors: | Alyssa Herrmann, Benjamin J. Samelson-Jones, Sami Brake, Renee Samelson |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2017-07-01
|
Series: | American Journal of Perinatology Reports |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1607055 |
Similar Items
-
Severe thrombocytopenia and intracranial hemorrhage in a newborn with Noonan syndrome and neonatal alloimmune thrombocytopenia
by: Rebecca Carter, et al.
Published: (2022-05-01) -
Antibody formation in pregnant women with maternal-neonatal human platelet antigen mismatch from a hospital in northern Taiwan
by: Wan-Hua Yang, et al.
Published: (2014-01-01) -
A Non-Invasive Strategy for Neonatal Alloimmune Thrombocytopenia Diagnosis: Newborn Platelet Genotyping with Buccal Swabs
by: Gérald Bertrand, et al.
Published: (2016-07-01) -
A Case of Alloimmune Thrombocytopenia, Hemorrhagic Anemia-Induced Fetal Hydrops, Maternal Mirror Syndrome, and Human Chorionic Gonadotropin–Induced Thyrotoxicosis
by: Venu Jain, et al.
Published: (2013-01-01) -
Assessment of the clinic-pathological profile of patients with pancytopenia
by: Mohan Tiwari, et al.
Published: (2023-01-01)